MicroRNA-409-5p Inhibits GIST Tumorigenesis and Improves Imatinib Resistance by Targeting KDM4D Expression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-409-5p Inhibits GIST Tumorigenesis and Improves Imatinib Resistance by Targeting KDM4D Expression
Authors
Keywords
-
Journal
Current Medical Science
Volume 43, Issue 5, Pages 935-946
Publisher
Springer Science and Business Media LLC
Online
2023-10-13
DOI
10.1007/s11596-023-2715-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR‐409‐5p negatively regulates Wnt/Beta catenin signaling pathway by targeting Lrp‐8
- (2019) Ravi Prakash et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling
- (2018) Fuqing Hu et al. Molecular Cancer
- Regulation of microRNA function in animals
- (2018) Luca F. R. Gebert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC
- (2018) Young-Jun Jeon et al. Nature Communications
- MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1
- (2017) Hong Yu et al. TUMOR BIOLOGY
- Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4
- (2016) Petra Hartmann et al. Nature Communications
- Antiangiogenic VEGF-Ax: A New Participant in Tumor Angiogenesis
- (2015) S. M. Eswarappa et al. CANCER RESEARCH
- MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression
- (2015) Rongpan Bai et al. INTERNATIONAL JOURNAL OF CANCER
- Determining the role of microRNAs in psychiatric disorders
- (2015) Orna Issler et al. NATURE REVIEWS NEUROSCIENCE
- miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer
- (2014) S. Josson et al. CLINICAL CANCER RESEARCH
- PIK3R3 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Colorectal Cancer
- (2014) G. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control
- (2013) Emanuele de Rinaldis et al. BMC GENOMICS
- Gastrointestinal stromal tumour
- (2013) Heikki Joensuu et al. LANCET
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Developing therapeutic microRNAs for cancer
- (2011) A G Bader et al. GENE THERAPY
- Histopathology of gastrointestinal stromal tumor
- (2011) Markku Miettinen et al. JOURNAL OF SURGICAL ONCOLOGY
- Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
- (2011) Heikki Joensuu et al. LANCET ONCOLOGY
- Tumor-specific Expression of MicroRNA-26a Suppresses Human Hepatocellular Carcinoma Growth via Cyclin-dependent and -independent Pathways
- (2011) Lizao Chen et al. MOLECULAR THERAPY
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
- (2009) Janaiah Kota et al. CELL
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
- (2009) Junfang Ji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
- The Genetic Signatures of Noncoding RNAs
- (2009) John S. Mattick PLoS Genetics
- Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
- (2008) Toshirou Nishida et al. International Journal of Clinical Oncology
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now